SCHEMBL3456263

SCHEMBL3456263

O=C(O)N1CCc2c[nH]nc2C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.34
NOTUM Q6P988 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33
TAAR1 Q96RJ0 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33
ROCK2 O75116 1/20 0.32
HSD17B10 Q99714 2/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TMPRSS2 O15393 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4067432 0.87 ROCK2 (0.34) GAANOTUMKDM4EMEN1KMT2A
SCHEMBL5072631 0.80 ABHD6 (0.32) GAAMEN1KMT2AMAPTTAAR1
SCHEMBL13070270 0.79 KDM4E (0.54) NOTUMKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL28379894 0.78
SCHEMBL23856215 0.76 GAA (0.49) GAANOTUMKDM4EMEN1KMT2A
SCHEMBL3643075 0.73 NOTUM (0.42) GAANOTUMKDM4EMEN1KMT2A
SCHEMBL23779972 0.72 RYR2 (0.38) GAANOTUMKDM4EMEN1KMT2A
SCHEMBL1171647 0.71 ESR2 (0.48) KDM4ESMN1; SMN2MAPTHTT
SCHEMBL17317692 0.70 NAMPT (0.47) GAANOTUMSMN1; SMN2MAPTNPC1
SCHEMBL20364270 0.69 ESR1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3856178-A1 MONOACYLGLYCEROL LIPASE MODULATORS Janssen Pharmaceutica NV (BE) 2021-08-04 EP disclosed
WO-2020065613-A1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 WO disclosed
EP-2251340-A1 Substituted tetrahydro-1h-pyrazolo[3,4-c] pyridines, compositions containing same and use thereof Aventis Pharma S.A. (FR) 2010-11-17 EP disclosed
EP-1646632-A2 SUBSTITUTED TETRAHYDRO-1 I H /I -PYRAZOLO 3,4-C|PYRIDINES, COMPOSITIONS CONTAINING SAME AND USE Aventis Pharma S.A. (FR) 2006-04-19 EP disclosed
WO-2005007653-A2 SUBSTITUTED TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINES, COMPOSITIONS CONTAINING SAME AND USE AVENTIS PHARMA S.A. (FR) 2005-01-27 WO disclosed